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Analyses of cardiovascular development have shown an important interplay between
heart function, blood flow, and morphogenesis of heart structure during the formation
of a four-chambered heart. It is known that changes in vitelline and placental blood flow
seemingly contribute substantially to early cardiac hemodynamics. This suggests that in
order to understand mammalian cardiac structure-hemodynamic functional relationships,
blood flow from the extra-embryonic circulation needs to be taken into account and
its possible impact on cardiogenesis defined. Previously published Doppler ultrasound
analyses and data of utero-placental blood flow from human studies and those using
the mouse model are compared to changes observed with environmental exposures
that lead to cardiovascular anomalies. Use of current concepts and models related to
mechanotransduction of blood flow and fluid forces may help in the future to better define
the characteristics of normal and abnormal utero-placental blood flow and the changes in
the biophysical parameters that may contribute to congenital heart defects. Evidence from
multiple studies is discussed to provide a framework for future modeling of the impact
of experimental changes in blood flow on the mouse heart during normal and abnormal
cardiogenesis.
Keywords: embryonic heart, placenta, echocardiography, hemodynamics, Doppler ultrasound, blood flow, mouse,
human pregnancy
INTRODUCTION
The human embryonic heart is a cylindrical beating tube already
at 3 weeks of gestation. The earliest time at which human car-
diac function can be visualized using ultrasound is ∼6–7 weeks
of gestation. Despite technological advances, echocardiographic
patterns are still not sufficient to adequately visualize the human
embryonic heart circulation at the early stages of cardiac devel-
opment. The Doppler ultrasound patterns obtained during the
earliest stages that have been analyzed during human gestation
are similar to those observed for embryonic mouse heart func-
tion (Gui et al., 1996) and thus animal models remain useful to
analyze in vivo embryonic heart function in normally develop-
ing embryos and in those displaying abnormal cardiac function.
There has been an awareness from the early part of the last
century (Thompson, 1917; Le Gros Clark and Medawar, 1947)
that to interpret the generation of form and pattern of living
organisms, one needs to define not only the genetic factors that
determine the form of an organ, but also the influence of the
physical forces to which the system is exposed in its normal devel-
opmental environment. So it is with organogenesis of the heart.
In the last 10 years, a great deal has been learned about the role
of hemodynamic force on cardiovascular development. Much of
this knowledge has come from animal models and technologi-
cal advances that have enabled researchers to analyze blood flow
at earlier and earlier stages of cardiovascular development. The
emphasis of many of these studies has been on modeling effects
of intracardiac flow and how these forces are mechanotrans-
duced. This review is to address how hemodynamics related to
extra-embryonic circulations is associated with heart and vascular
development.
Blood flow early in development is dependent on the yolk
sac and development of the vitelline circulation. Later, as the
placental circulation becomes functional, both extraembryonic
circulations send blood to the developing heart. From studies
from a number of groups, the results demonstrate that hemo-
dynamic changes in the extraembryonic circulations, vitelline or
placental, can alter normal heart development to induce car-
diac anomalies. The objectives of this review are to provide
(i) evidence from animal-based hemodynamic studies carried
out on vitelline and placental circulations that have demon-
strated a relationship with changes in normal heart and vas-
cular development; (ii) evidence from human gestation using
Doppler ultrasound parameters that demonstrate changes in pla-
cental hemodynamics are associated with altered human heart
and vascular development; and lastly (iii) evidence from environ-
mental exposure studies using animal models that demonstrate
that fetuses displaying cardiac anomalies also show placental
abnormalities.
The concept of an importance of the heart-placenta axis
has been published earlier (Huhta and Linask, 2013; Linask,
2013). In this review emphasis is placed on studies that have
dealt with the contribution of vitelline and placental circulations
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in relation to heart development, both normal and abnor-
mal. In a recent editorial (Sliwa and Mebazaa, 2014) cit-
ing the work of Llurba et al. (2014) that is discussed below,
the authors concluded that an “evaluation of the relationship
between congenital heart defects (CHDs) and placenta-related
complications should be explored in further research.” The
intent for this review is to provide a brief overview of rela-
tionships that exist between CHDs and vitelline and placental
blood flow for investigators involved in mathematical model-
ing of cardiac hemodynamic effects and mechanotransduction.
It appears of benefit to this field to consider the role of placen-
tal blood flow, or even earlier, vitelline blood flow, and changes
therein to understand the role of extraembryonic blood flow
forces, often accompanied by hypoxia, in the formation of heart
anomalies.
DOPPLER ULTRASOUND PARAMETERS OF HEMODYNAMICS
INTRODUCTION
During the early 1990’s for analysis of abnormal mouse heart
development we used a breeding scheme that generates the tri-
somic 16 mouse model (Miyabara et al., 1982; Epstein et al.,
1985). In order to detect the one embryo in the litter that was
developing a heart defect related to the trisomy condition and to
carry out further analyses, we wanted viable embryos and also
the ability to do longitudinal analyses on heart function of the
same abnormally developing embryo within a litter. A more effi-
cient, high-throughput manner was needed. For this we adapted
for the first time for analysis of the embryonic mouse model the
use of non-invasive Doppler echocardiography (echo) to evalu-
ate each mouse embryo’s heart function and demonstrated that
echo can be used longitudinally to characterize normal cardiac
functional changes during mouse gestation (Linask et al., 1993;
Gui et al., 1996). The methodology worked surprisingly well
with even using clinical ultrasound instrumentation with a 7.5
mHz transducer that was available to us for these early analyses.
A detailed description of the methodology of doing the mouse
exams was reported separately (Linask and Huhta, 2000). Shortly
after our early studies, advances in non-invasive functional anal-
yses using Doppler echocardiography were made possible with
new ultrasound instrumentation for small animal imaging that
was equipped with 40 mHz transducers (Srinivasan et al., 1998;
Phoon and Turnbull, 2003; Phoon, 2006). A recent echocardio-
graphic longitudinal assessment of embryonic and fetal mouse
heart development using the high-frequency ultrasound system
has been published that correlates the hemodynamic ultrasound
analysis with the changes in mouse cardiac morphology dur-
ing development (Hahurij et al., 2014). These ultrasound studies
have allowed for a more sensitive measurement of physiologi-
cal parameters of embryonic hemodynamics in the mouse model
and at earlier time-points than previously was possible. It became
apparent that the ability to do the analyses non-invasively allowed
for more accurate quantitation of the physiological parameters
than when carried out invasively (Gui et al., 1996; Keller et al.,
1996; Phoon et al., 2000). We had also noticed in our early non-
invasive analyses, that when we opened the maternal abdomen to
carry out another echo exam on the same embryo, but this time
directly, the embryonic heart rates had dropped and therefore
quantitative reproducibility of the non-invasive data was not
possible (Gui et al., 1996).
CARDIAC AND PLACENTAL ULTRASOUND PARAMETERS SUMMARIZED
Embryonic mouse heart rate increases as heart formation pro-
gresses during gestation. Accurate measurement of heart rate
under normal physiological conditions is important because the
other cardiac parameters of cardiac ejection, filling, and car-
diac output are affected by the heart rate (Phoon et al., 2000).
The normal Doppler characteristics of umbilical blood flow dur-
ing mouse gestation indicated that the heart rate, peak blood
flow velocities and velocity time integrals increased from E9.5
to 14.5, indicating increasing stroke volume and cardiac output
(Gui et al., 1996; Phoon, 2001). Placental impedance was shown
to decrease with gestation (Phoon et al., 2000). Similar results
were reported in a subsequent study analyzing the developmen-
tal changes in hemodynamics of uterine artery, umbilical, and
vitelline yolk sac circulation during mouse gestation (Mu and
Adamson, 2006). It was also observed the initial heartbeats begin
around 5 somite-stage and blood flow at the 8- to 10-somite stage
(Ji et al., 2003). This would correspond to ∼E8.5 in the mouse
or ∼33 h in the chick embryo. The first heartbeats are driven by
the Na-Ca Exchanger (Koushik et al., 2001; Linask et al., 2001).
To obtain more information on placental function and devel-
opment, non-invasive Doppler ultrasound of the umbilical artery
can be used to provide an indirect analysis of umbilical blood
flow and placental resistance (Maclennan and Keller, 1999; Phoon
et al., 2000; Mu and Adamson, 2006). Using the C57Bl6 mouse
model, we assessed different parameters of the fetal cardiac cycle
and umbilical blood flow on E15.5 in response to acute expo-
sure of embryos on E6.75 to different environmental factors
(Han et al., 2009; Serrano et al., 2010). We routinely moni-
tor embryos on E 15.5, because a four-chambered heart is now
present with functional valves. During the echo exam, the preg-
nant mouse is anesthetized and core temperature monitoring is
performed throughout the procedure to maintain body temper-
ature. E15.5 corresponds to approximately week 10 of human
gestation. The abnormal echocardiographic patterns relating to
myocardial and valve defects upon environmental exposures have
been published earlier (Han et al., 2009; Serrano et al., 2010). For
venous hemodynamics, the presence of flow reversal during atrial
contraction (A wave) in the ductus venosus and the presence
of umbilical venous pulsations was used as the sign of abnor-
mal flow/congestive heart failure (Huhta, 2005). The abnormal
echo patterns relating to the myocardial and valve (atrioventricu-
lar and semilunar) defects after environmental exposures display
variability, because not all embryos within a litter are at the
same developmental stage. In our experimental exposure studies
peak systolic velocity (PSV) and the end-diastolic velocity (EDV)
were measured for embryos displaying cardiac defects within each
experimental group and the results were averaged and compared
to the same parameters in control embryos. The pulsatility (PI =
(PSV − EDV)/time-averaged velocity, Gosling et al., 1991) and
resistance (RI = PSV − EDV)/PSV, Giovagrandi et al., 1987)
indices are discussed and reviewed below.
The elements of resistance to flow are those that are present in
any other vascular bed, namely the number, length and diameter
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of the arteries, and the viscosity of the blood. The relationship
is derived from Poiseuille’s Law: Q = π r4/8n l, where Q is flow,
r is radius, n is blood viscosity and l is vessel length. Although, a
small change in vessel radius may be sufficient to increase the flow
(4th power), vessel length and blood viscosity are factors that can
influence the flow on a more minor scale. Therefore, when the
umbilical arteries are narrow, they offer high resistance to flow
as in first-trimester human pregnancy or in pathological condi-
tions, such as when the umbilical vessels may be affected by an
enviromental event or mother’s vascular disease (pre-eclampsia
and IUGR). Normally the pulsatility of arterial velocity wave-
forms increases when downstream resistance increases (Mu and
Adamson, 2006).
ANIMAL-BASED HEMODYNAMIC STUDIES CARRIED OUT
ON VITELLINE AND PLACENTAL CIRCULATIONS
DEMONSTRATING A RELATIONSHIP WITH CHANGES IN
NORMAL HEART AND VASCULAR DEVELOPMENT
Development of functional circulatory systems for nutrient and
oxygen exchange is imperative for the growth and survival of the
embryo. Initial growth of the embryo is dependent on the vitelline
circulation to the yolk sac. Abnormalities in yolk sac hemodynam-
ics can result in embryonic malformations or lethality (Hogers
et al., 1995, 1999). Later from embryonic day 10.5 (E10.5) dur-
ing mouse gestation embryonic and fetal growth is dependent on
umbilical blood flow via the chorioallantoic placenta. The hemo-
dynamic relationships of these circulatory systems are discussed
below.
YOLK SAC VITELLINE CIRCULATION
The period of trophoblast invasion that begins on embryonic day
(E) 8.5 in themouse coincides approximately with when the tubu-
lar heart first begins to beat in the mouse embryo (Phoon, 2001).
Using Swiss–Webster mice, blood velocity was detected at E 8.5 in
the vitelline artery supplying the yolk sac placenta in all embryos
that were analyzed. It is to be noted that to image at these early
developmental stages, a “semi-invasive” imaging technique was
used by making a lower abdominal incision to access the embryo.
This was done to optimize imaging of these small-sized embryos.
Flow parameters under these semi-invasive conditions may not be
completely physiological, but it is the best characterization that
we currently can attain at this early developmental stage. Peak
velocity increased almost sevenfold between E8.5 and E13.5 at
which time it reaches a plateau and remains stable until term (Mu
and Adamson, 2006). Positive EDV was detected in the vitelline
artery only at E18.5. Despite higher peak velocities reached in
the umbilical arteries, the yolk sac circulation is thought to be
the most important source of nutrition for the embryo until
E13.5, at which stage the umbilicoplacental circulation becomes
paramount and the PSV has reached its plateau.
In human pregnancy, the vitelline artery and umbilicoplacen-
tal circulations are functional from the onset of the heart beat
until the end of the organogenetic period (∼9 weeks). The yolk
sac in late mouse gestation appears to play a role in calcium trans-
fer, immunoglobulin G, and amino acid transport. In the mouse
both the placenta and yolk sac show hematopoiesis until E17
(Alvarez-Silva et al., 2003). In the human after organogenesis is
FIGURE 1 | Development of the avian extra-embryonic vasculature is
shown displaying the normal modeling of blood vessels in the yolk
sac (vitelline circulation) in an embryonic stage 14 quail embryo grown
on yolk in shell-less culture.
completed during the first trimester, the yolk sac regresses and
vitelline blood velocities are no longer detected.
Concomitant with heart formation, blood and vascular vessels
first form in the extraembryonic yolk sac (Figure 1 as observed
in the avian model). Similarly by E8.5 a capillary network of
endothelial-lined channels is evident in the mouse yolk sac. The
vessels ultimately connect to the embryo, completing a circula-
tory loop between embryonic and extra-embryonic tissues. The
first blood cells and endothelial cells are forming in yolk sac blood
islands beginning at E7.0 in the mouse (Mcgrath et al., 2003). By
E8.0 thousands of nucleated primitive red blood cells have formed
within a vascular plexus in the yolk sac. Once the heart begins
to beat, primitive erythroblasts originating in the yolk sac can be
found in the embryo. The data suggest that a fully functional cir-
culation is established after E10.0. The yolk sac vascular network
remains a site of progenitor production even as the fetal liver later
becomes a hematopoietic organ (Mcgrath et al., 2003).
Venous clip avian model and hemodynamics
Early studies analyzing the impact of vitelline hemodynamics
on heart development were carried out using the chick model
because of ease of experimental manipulation and visualization
of results. Using a venous clip model whereby the right lateral
vitelline vein was obstructed, the venous return and intracardiac
laminar blood flow patterns were altered, with secondary effects
observed on the mechanical load of the embryonic myocardium
(Stekelenburg-de Vos et al., 2003). All hemodynamic parameters
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measured were seen to decrease acutely after the clipping. The
effects were thought to be correlated with the observed cardiac
malformations that formed in these embryos. Subsequently, in a
pressure-volume loop analysis of the venous clippedmodel, it was
demonstrated that clipping resulted in systolic and diastolic ven-
tricular dysfunction. The ventricular functional changes preceded
morphological abnormalities that became apparent in later devel-
opmental stages (Stekelenburg-de Vos et al., 2007). Shear stress is
positively correlated to blood flow. Blood flow-related shear stress
and circumferential strains have been associated with embryonic
heart remodeling. These blood flow forces are transduced intra-
cellularly via mechanotransducing molecular complexes, as for
example, integrin-mediated complexes or tenascin C-associated
(Linask and Vanauker, 2007; Garita et al., 2011).
In addition to the molecular sensors, an ultrastructural cellu-
lar adaptation is present on endothelial cells for mechanosensing
called the primary cilium (Van der Heiden et al., 2006; Clement
et al., 2009). The primary cilia are connected to the cytoskeletal
microtubules and transmit information about the amount and
direction of blood flow into the endothelial cells. During looping
and heart remodeling from a C-shaped tube, the highest shear
stress is experienced by the inner heart curvature. When shear
stress is experimentally altered, this inner curvature region is
highly affected and is associated with the development of CHDs
(Hierck et al., 2008). The shear stress changes were shown to affect
gene expression with KLF-2 being expressed in regions of high-
est shear stress and ET-1 and NOS-3 expressed in later stages in
regions of shear stress (Groenendijk et al., 2004, 2005). We also
observed primary cilia associated with embryonic cardiomyocytes
within the embryonic myocardium during looping (Garita et al.,
2011). In this optical coherence tomography (OCT) analysis of
the looping chick heart, during each heartbeat the myocardial
wall during filling pushes against the splanchnopleure and rolls
for a short duration along the extraembryonic membrane, and
then quickly moves away during systole. It was suggested the car-
diomyocyte cilia have a role in sensing outside pressures of the
splanchnopleural membrane to define spatially the embryonic
heart looping process, as the loop tightens and changes with each
heartbeat to eventually form the four-chambered heart.
Vascular remodeling and blood vessel structure formation
It appears that vascular remodeling and blood vessel struc-
ture formation in the mouse yolk sac are influenced also by
hemodynamic forces (Lucitti et al., 2005, 2007). Using con-
focal microscopy and fluorescent dextran labeling, the studies
demonstrated that the heart is a functional pump as soon as
the myocardium begins to contract and that there is a signifi-
cant period of plasma flow preceding the entry of erythroblasts
into the circulation. Embryos with impaired cardiac contractil-
ity (homozygousMyosin light chain2amice,Mlc2a−/−) displayed
slow oscillatory flows instead of the normal pulsatile laminar-
flow of normal embryos. The homozygote embryos displayed
abnormal reduced plasma flow and delayed erythroblast circula-
tion and defective vascular remodeling. When plasma flow rates
were normal, but the erythroblasts were sequestered in the blood
islands, lowering the hematocrit and decreasing shear stress, ves-
sel remodeling was impaired indicating this process depends on
erythroblast flow. The remodeling defects in the low-hematocrit
embryos could be rescued by restoring the viscosity of the blood
by injection of a high-molecular weight synthetic sugar (Lucitti
et al., 2007). Expression of molecules involved in force transduc-
tion as eNOS was also restored to the endothelial cell membranes
in response to the changes in mechanical force.
Flow forces and assembly of endothelial adherens junctions
It has been demonstrated in in vitro studies that the size
of adherens junctions and tight junctions between endothelial
cells closely match with the intercellular forces for the specific
flow conditions (Ting et al., 2012). Laminar flow can increase
cytoskeletal tension and disturbed flow decreases cytoskeletal ten-
sion in response to the shear flow conditions affecting in turn the
assembly of cell-cell adherens junctions. Thus, the tractions forces
have the ability to also regulate the barrier function of endothelial
cells and tissue integrity.
UMBILICO-PLACENTAL CIRCULATION
Organization of the placenta
Although the gross anatomy of the human and mouse placenta
are dissimilar in a number of ways, both share many cellular
and molecular characteristics (Rossant and Cross, 2001). Briefly,
the placenta is composed of both maternal and fetal tissues.
The mouse placenta is composed of three layers: the maternal
decidua that is of maternal origin uterine stromal cells across
whichmaternal blood passes to the implantation site through spi-
ral arteries; the junctional zone through which maternal blood
vessels lead into and out of trophoblast giant cell-lined vascular
spaces; and the labyrinth layer where nutrient and gas exchange
occurs within a high surface area comprised of fetal and mater-
nal vessels (Figure 2). A barrier, however, is maintained between
the fetal and maternal circulations. The human placenta also has
three similar layers: the maternal decidua layer with spiral arter-
ies; a basal plate that is analogous to the junctional zone; and a
labyrinth-like layer where the placental villi are organized into
cotyledons, but is not as densely packed and the intervillous space
is more open when compared to the rodent placenta.
Vascular remodeling and trophoblast invasion
Adequate utero-placental blood flow is necessary for normal
pregnancy outcome. Vascular remodeling that takes place dur-
ing utero-placental circulation provides sufficient blood flow
throughout pregnancy. The vascular remodeling is mediated by
trophoblast invasion of uterine spiral arteries, increased shear
stress, and angiogenic and humoral biochemical factors (Osol and
Mandala, 2009). What is unique to the placenta in both in human
and rodent placentas is that the maternal vasculature is lined by
fetal cells of the trophoblast lineage and not by maternal endothe-
lial cells. Primary trophoblast cells that undergo invasion of the
maternal blood vessels develop from the trophectoderm layer of
the blastocyst (Rai and Cross, 2014). These primary trophoblast
cells contribute to the formation of the decidua and promote the
formation of maternal blood vessels that deliver blood to the pla-
centa. These trophoblasts invade and assume the location and
function of endothelial cells within the maternal vascular spaces
in the placenta (Rai and Cross, 2014). The trophoblasts cells can
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FIGURE 2 | Schematic diagram of the fetal-placental tissue organization and circulation.
also undergo morphogeneis forming vascular tubes de novo. The
trophoblast invasion begins at approximately embryonic day (E)
8.5 in the mouse (in human pregnancy the first 10–12 weeks
of gestation) (Rossant and Cross, 2001). The timing of invasion
coincides approximately with the period that blood flow through
the tubular heart first is detected in the mouse embryo (Phoon,
2001). After the first 10–12 weeks of human gestation as a result
of the physiological change associated with trophoblast invasion,
the diameter of the uterine spiral arteries increases, reducing
impedance to flow. Abnormalities in the process can result in ele-
vated resistance and pulsatility indices, which are associated with
adverse maternal and offspring outcome.
The placental arterial tree inmice is supplied by a single umbil-
ical artery, which branches into fetoplacental arteries and pene-
trates into the labyrinth region to the junctional zone (Figure 2).
Perfusion of the arterial tree begins at E 9.5 as detected by flow in
the umbilical artery (UA). Fetal growth is observed with increases
in the diameter of the UA and in UA blood velocity that increases
up to term at E 21 in the mouse. With the increase in diameters of
the fetoplacental arteries there is a decrease in calculated vascular
resistance of the arterial tree, that is similar to what has been
described during human pregnancy (Mu and Adamson, 2006).
This decrease in vascular resistance relates to the increased vol-
ume and surface area of thematernal blood spaces in the placental
labyrinth of the mouse during pregnancy (Coan et al., 2004).
Positive end-diastolic velocities are first detected at E15.5 and then
increase to term. This coincides with the timing of the matura-
tion of the four-chambered heart and placental development. It
was shown that the PSV decreased between the maternal arte-
rial canal and further decreased upon entering the labyrinth (Mu
and Adamson, 2006). Low velocity in the terminal trophoblast-
lined exchange spaces helps to promote the effective exchange of
nutrients, gases, and waste products between the maternal and
embryonic/fetal circulations.
Evidence for abnormal placental development and function with
abnormal cardiovascular development
The link of abnormal placental development and function
with abnormal cardiovascular development is suggested by sev-
eral studies using animal models. Using the mouse model,
the results from germ-line ablation of two specific genes, as
p38α-mitogen activated protein (MAP) kinase or of peroxisome
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proliferator-activated receptors (PPARs), demonstrated the above
gene expression was critical for proper placental function and,
when knocked out only in the placenta, resulted in cardiac
defects. When the placental function was rescued, however, via
aggregation with tetraploid embryos, the cardiac defects were
rescued (Barak et al., 1999; Adams et al., 2000). In a study
using the sheep animal model, using surgery before concep-
tion to reduce placental mass and induce fetal growth restric-
tion, this resulted in an alteration of heart development in the
sheep fetus (Morrison et al., 2007b). The placental restriction
resulted in increased fetal hypoxia, intrauterine growth restric-
tion (IUGR) and elevated plasmacortisol levels. There was no
difference in relative heart weights between the control and pla-
centa restricted fetuses. However the proportion of mononucle-
ated cardiomyocytes increased. In relation to the relative size of
the cardiomyocytes when expressed relative to heart weight, the
cardiomyocytes were larger in the placenta restricted model in
comparison to control fetuses. In this study effects on blood flow
were not specifically analyzed and the cardiac effects may be due
to an adaptation to the chronic hypoxia that resulted and hence
the delay in binucleation and differentiation of the cardiomy-
ocytes and a reduction in their number. Another study on sheep
showed a similar link with IUGR and cardiomyocyte maturation
and coronary artery function in fetal sheep (Bubb et al., 2007). It
would appear these above-describedmyocardial changes may also
induce changes in cardiac output that was not directly addressed.
In general IUGR is not associated with development of cardiac
defects. It is possible that in cases where embryos have severe
hypoxia, IUGR, and heart defects, these embryos are not viable.
Effects of hypoxia on heart development were more directly
addressed in quail embryos incubated under hypoxic conditions
(16% oxygen) (Nanka et al., 2008). Their studies demonstrated
thin ventricular walls developed and irregularities were observed
in the development of the coronary tree. The hypoxia also resulted
in increased capillarity and trabeculation. Subsequently, normal
vascularization did not occur, leading to heart failure and embry-
onic death. For further discussion of effects of hypoxia on the
fetus and heart development, a number of reviews have been
published (Dunwoodie, 2009; Patterson and Zhang, 2010). In
summary, studies suggest that possibly in themammalian embryo
a threshold of hemodynamic force, when present, allows nor-
mal development, but when below that threshold as a result of
abnormal development, increasing severity of defects occur, or
if the changes are very severe, the condition becomes lethal. The
thresholds would need to be empirically determined.
STUDIES FROM HUMAN GESTATION USING DOPPLER
ULTRASOUND DATA DEMONSTRATING CHANGES IN
PLACENTAL HEMODYNAMICS AFFECTING
CARDIOVASCULAR DEVELOPMENT
FAILED TROPHOBLAST INVASION AND CONGENITAL HEART DEFECTS
During early human pregnancy, before the intervillous space
opens between 10 and 12 weeks of gestation (corresponding to
∼16.6 days of mouse gestation), the development of the placenta
in normal human pregnancies occurs as a “non-invasive tro-
phoblast phenotype” in which the hypoxic environment prevents
trophoblast invasion into the uterus that is mediated by cytokines
as TNF alpha, IL-1 alpha, and 1-beta, VEGF and plasminogen
activator inhibitor-1 (Caniggia et al., 2000). Subsequently, the
extravillous trophoblast cells acquire “an invasive trophoblast
phenotype” migrating into the uterine wall, replacing the mater-
nal vascular wall, and transforming maternal spiral arteries from
high resistance vessels into low-resistance vessels, allowing the
entry of oxygenated and nutrient-rich maternal blood into the
intervillous space. Failed trophoblast invasion and a high resis-
tance have been described in women who subsequently deliver
infants with growth restriction (Schulman et al., 1986). A recent
report associates congenital cardiac defects with abnormal tro-
phoblast invasion and abnormal placental angiogenesis (Llurba
et al., 2014). In this case-control study of pregnant women car-
rying fetuses with major congenital cardiac defects, maternal
venous blood, cord blood samples from fetuses with CHD and
from non-CHD control fetuses were analyzed for angiogenic
and anti-angiogenic factors. In termination-of- pregnancy cases,
heart tissue was also analyzed from abnormal and normal fetal
hearts. The study demonstrated the presence of hypoxia in abnor-
mal human fetal hearts with an overexpression of HIF-2 alpha
and HO-1. In the maternal serum of women carrying fetuses
with major heart defects associated primarily with conotruncal
and septal-valve defects, maternal serum placental growth fac-
tor (PlGF) was decreased and soluble fms-like tyrosine kinase-1
(sFlt-1) increased, suggesting impaired placental angiogenesis. A
correlation between lower maternal PlGF levels and birth weight
percentile in the CHD babies was observed suggesting that the
placental impairment contributed to diminished growth poten-
tial of fetuses with CHD. In addition these fetuses demonstrated
a trend toward a higher umbilical and lower middle cerebral
artery Doppler resistance compared with controls. The authors
concluded that evaluating the relationship between CHD and
placental-related problems is an important area to pursue in
future research.
UMBILICAL BLOOD FLOW AND CARDIAC OUTPUT
It is established that placental volume blood flow is a major
determinant of early cardiac output, fetal growth, and well-being
(Acharya et al., 2004, 2005; Vimpeli et al., 2009b). The blood
flow through the umbilical cord corresponds to 17% of combined
cardiac output at 10 weeks and 33% by 20 weeks (Kiserud and
Acharya, 2004). The increase in umbilical flow optimizes fetoma-
ternal gas and nutrient exchange and provides for healthy fetal
outcomes. As seen in the Llurba et al. study, congenital malfor-
mations can be associated with hemodynamic changes occurring
in the placenta and fetus, often resulting in smaller placentas
and IUGR of the fetus. The circulatory effects may relate to the
maturation of vascular responses in a number of organ systems
(Rudolph, 2010): The effects of hemodynamic changes can lead
to CHDs as well as affecting cerebral development in the fetus, as
it has been measured that ∼13% of the combined cardiac out-
put between 11–20 weeks of gestation goes to the upper body,
including the brain, during this period of pregnancy (Vimpeli
et al., 2009a; Arduini et al., 2011). That cardiac and neural
effects can be associated is suggested also by a report that pro-
vides evidence that children with CHDs are at increased risk of
developmental disorders or developmental delay (Marino et al.,
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2012). The hemodynamic changes may severely affect neonatal
survival or well-being, or when subtle, have long-term impacts
relating to developmental disabilities or possibly adult cardiovas-
cular disease. The latter relates to the Barker hypothesis regarding
developmental origins of adult cardiovascular disease (Barker,
2007, 2008).
PREGNANT MOTHERS WITH CHDs AND EFFECTS ON PLACENTA AND
FETUS
In the mammalian model abnormal cardiac development lead-
ing to congenital heart disease (CHD) has been associated
with abnormal placental development with abnormal trophoblast
invasion and blood vessel remodeling, abnormal blood flow, and
the resultant changes in the transfer of nutrients and oxygen from
the mother to the fetus. Impaired placental blood flow has been
demonstrated also in pregnant women with CHDs and compro-
mised heart function (Pieper et al., 2013) and was linked to the
observed increased incidence of obstetric and offspring compli-
cations in the pregnancies of women with CHD. In this cited
study it was analyzed whether preexisting cardiac dysfunction in
the pregnant women with CHD can lead to abnormalities in pla-
cental development and abnormal utero-placental Doppler flow.
The Doppler flow indices of the women with CHD indicated a
higher resistance in the utero-placental circulation throughout
pregnancy than seen in healthy women. Results showed that the
abnormal utero-placental flow lead to increased IUGR and con-
tributed to the observed pregnancy complications in comparison
to control healthy pregnancies. Complications related to findings
that more children of women with CHD were small for their ges-
tational age (16.3 vs. 4.3% in control); congenital heart disease
occurred in 4.8% of offspring of CHD vs. 0% of healthy women’s
offspring; offspring death occurred in 2.9% of the CHD group
and 0% of the healthy group. Causes of death in the offspring
related to spina bifida, complex heart disease, hydrops fetalis, and
placental insufficiency.
Dysfunction of placental flow, as is seen to occur in human
IUGR fetuses, leads to changes in intra-fetal cardiac dynamics
that result from alterations in the preload, afterload, ventric-
ular compliance and myocardial contractility (Kiserud et al.,
2006). For example, the increase in placental and aortic (isthmus)
impedance caused by vasoconstriction resulted in an increase
in the right ventricular afterload. Subsequently, to adapt to
hypoxemia, the vasodilatation of such vital organs as the brain,
heart, adrenals and spleen occurred. Cerebral centralization and
the increase of the ductus venosus flow also contributed to a
greater increase in the preload of the right ventricle (RV) and
to a preferential flow to the left ventricle (LV) that was associ-
ated with decreased LV compliance. As the placental resistance
progresses and the cardiac overload increases, the coronary per-
fusion can lose its compensatory ability, leading to myocardial
cell damage with decreased contractility and reduced cardiac
output (Baschat et al., 1997; Crispi et al., 2008). The latter
two effects were significantly correlated with increased perina-
tal morbidity and mortality. As observed in human and mouse
pregnancy, abnormalities in utero-placental and umbilical arterial
hemodynamics are associated with placental abnormalities and
adverse cardiovascular outcomes.
HEMODYNAMIC CHANGES AND CARDIAC DEFECTS IN THE
MOUSE MODEL WITH ENVIRONMENTAL EXPOSURES
CROSS-TALK BETWEEN PLACENTA AND CARDIOVASCULAR SYSTEMS
Our results with the C57Bl6 mouse model demonstrated that
a single environmental exposure occurring during gastrulation
(on E6.75 of mouse gestation; extrapolated to human preg-
nancy ∼ between 16 and 19 days after fertilization), many dif-
ferent forms of cardiac birth defects can arise. The experimental
paradigm in our studies was to expose mouse embryos by a sin-
gle intraperitoneal (i.p.) injection to the environmental factor at
6 PM on embryonic day E 6 (i.e., E 6.75) that corresponds to gas-
trulation during which cardiac and placental cell fate decisions
are being made. Similar cardiac structural and functional defects
in the mouse embryos resulted with the one-time exposure to the
drug lithium (Li+), alcohol (EtOH), or homocysteine (HCys), the
latter a natural metabolite and a marker of folate1deficiency (Han
et al., 2009; Serrano et al., 2010). With this gestational timing of
exposure, we observed chiefly heart outflow related defects, valve
defects (semilunar- and pulmonary-valve related), myocardial
wall thickness changes, and changes in myocardial contractility.
The embryo displayed IUGR and smaller placentas in compar-
ison to control embryos. The data from the exposure studies
led to the concept that both organ-systems, cardiac and placen-
tal, are important during cardiovascular development, including
in the formation of the more mature four-chambered heart. It
was evident that cell and molecular changes occurred in both
the heart and placenta organ-systems after exposure and affected
blood flow. There appears to be continuous cross-talk between
the two organs via blood flow forces and biochemical signaling to
adapt one’s function to the needs of the other, and specifically,
for growth of the embryo. Our data demonstrated both organ
systems are affected by the exposures and one cannot say which
comes first. Both adapt to the changes that each organ detects,
but if the alterations that have taken place due to the exposures
are severe enough, it will lead increasingly to compromised func-
tion and subsequent abnormal tissue and organ development,
and possible death of embryos severely affected.
Abnormal branching of the fetoplacental arterial tree seems to
take place both in human pregnancies and in mouse gestation
where fetal growth restriction is evident with the umbilical artery
hemodynamics compromised, as we reported with exposure of
the pregnant mouse to the above-listed three environmental fac-
tors. Little is known about themechanisms controlling the growth
and the structure of the fetoplacental arterial tree. Although with
environmental exposures, it is often disorganized and decreased
vascularization is noted (Rennie et al., 2014).
CHANGES IN UMBILICAL ARTERY PULSATILITY INDEX AND
RESISTANCE INDICES SUMMARIZED
Umbilical artery flow is indicative of blood moving from the
fetus to the placenta and the umbilical vein takes blood from
the placenta to the fetus. The volume coming to the pla-
centa, however, should be equal to volume going out of the
1Dietary Supplement Fact Sheet: Folate. National Institutes of Health, Office
of Dietary Supplements. Available online at: http://ods.od.nih.gov/factsheets/
Folate-HealthProfessional/
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Table 1A | Comparison of UA RI on E 15.5.
Treatment UARI
Hcysa (n = 30) 0.73
Lithiumb (n = 23)* 0.87
EtOHc (n = 26)* 0.93
Controld (n = 24) 0.7
a,b, and c compare with d separately to get p-value; *p < 0.000005, highly
significant.
Table 1B | Comparison of UA RI on E15.5.
placenta, as it is a closed system. There are strong clinical
associations between abnormalities of umbilical artery hemo-
dynamics, placental pathology and fetal growth restriction in
the human. Although these parameters have been determined
non-invasively by other investigators in the mouse using the
Swiss-Webster mouse strain (Phoon et al., 2000) and the out-
bred CD-1, Harlan Sprague Dawley mouse (Mu and Adamson,
2006), because of possible strain differences (Rennie et al., 2012),
we determined from values in our published data the normal
umbilical artery (UA) blood flow patterns for the C57Bl6 fetal
E15.5 mouse used in our exposure studies and compared with
the control embryos exposed to physiological saline only by i.p.
injection, and with embryos exposed by i.p. injection to the
experimental environmental factors (Tables 1A,B). The trends
and parameters of the control embryos were similar to those
previously reported by others using the different mouse strains,
although differences were noted between our controls receiv-
ing an injection and those that were uninjected (Han et al.,
2009).
In human pregnancy, Doppler analysis of the umbilical cir-
culation during second and third trimesters of pregnancy has
proven to be a good predictor of fetal status. The significance
of an abnormal umbilical Doppler in the first trimester has not
been well established to be a predictor of early human pregnancy
complications. Pulsatility index (PI) formula for the umbilical
artery is the same as for the uterine artery, but in human preg-
nancy the EDV is not calculated for early stages, since it does
not appear until 10 weeks of pregnancy, when measurements
are only then attainable. It is similar in mouse gestation where
EDV was very low in the umbilical artery before E14.5; detection
FIGURE 3 | Longitudinal Analysis: Doppler ultrasound parameters
from E11.5 to E18.5 during mouse gestation. (A) Umbilical artery (UA)
Pulsatility Index (PI); (B) Umbilical artery (UA) resistance index (RI);
(C) Umbilical artery (UA) PSV and EDV.
rate was 38% at E 15.5 and 94% at E 18.5 (Mu and Adamson,
2006).
In our longitudinal study of the normal C57Bl6 mouse (unin-
jected) pregnancy, Doppler ultrasound measurements were car-
ried out daily and the UA, PI, RI, systolic and end-diastolic
peak velocities were calculated. To summarize these results,
as well those of others, the PI increased from a low of 0.98
on E11.5 to 1.31 on E 15.5 and decreased to 1.1 on E 18.5
(Figure 3A). The RI results showed a similar pattern to the
PI (Figure 3B). The systolic peak velocity (PSV) in umbilical
artery increased with gestational age, significantly after E 15.5
(Figure 3C). The end-diastolic wave (EDV; Figure 3C) could be
detected on E 11.5 and increased after E 15.5, concomitantly
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with time of PI and RI decreasing. These control mouse findings
are similar to that described previously (Mu and Adamson,
2006).
Comparing the normal control pregnancy RIs (0.70) with
the UA RIs of environmentally exposed E 15.5 embryos
(Tables 1A,B): lithium (Li, 0.87) and ethanol (EtOH, 0.93) expo-
sures significantly increased the RIs. With HCys exposure (0.73)
the UA RI did not change significantly as compared to the control.
The UA PI pattern, reported earlier, was similar to the RI and is
not shown.
In summary, an elevation of HCys generally did not have
a significant effect on placental development and blood flow,
as did exposure to ethanol and lithium. This is reflected
also in the effects on heart physiology. As published earlier,
HCys displayed the best outcome of heart structure and func-
tion, followed by the poorer outcome with lithium’s effects
and with the most severe effects observed with alcohol expo-
sure (Han et al., 2009; Serrano et al., 2010; Han et al.,
2012).
Acute alcohol exposure during gastrulation induced the most
severe effects. Alcohol induced abnormal valve formation, poor
myocardial performance and abnormal placental development
in more than 86% of embryos. Intraembryonically, echo car-
diac parameters showed a significantly decreased cardiac cycle
length, increased heart rate, altered IRT and ICT percent-
ages, increased myocardial performance index (0.47 in con-
trol to 0.62 in alcohol exposed) reflecting increased afterload,
and a decreased outflow velocity (36.07 in control decreasing
to 26.73 with alcohol exposure) (Serrano et al., 2010). In an
OCT study using an avian model, alcohol exposure was also
demonstrated to alter early cardiac function and the functional
changes preceded and were hypothesized to contribute to the
observed late-stage valve and septal defects (Karunamuni et al.,
2014).
In the future, it would be interesting to use these environ-
mentally induced changes in cardiac function and the observed
changes in the quantitative parameters of yolk sac and utero-
placental blood flow to model possible biophysical effects
of these flow alterations over time during abnormal cardiac
morphogenesis.
MORPHOMETRIC PARAMETERS CHANGE WITH ALTERED
HEMODYNAMICS INDUCED BY ENVIRONMENTAL EXPOSURES
Lithium, homocysteine, and alcohol effects
IUGR is associated with placental and heart development
(Corstius et al., 2005;Morrison et al., 2007a). BothWnt/β-catenin
signaling and homocysteine have been associated with placen-
tal development (Kamudhamas et al., 2004; Mohamed et al.,
2008) and as we and others have shown with heart development
(Rosenquist et al., 1996; Foley and Mercola, 2005; Manisastry
et al., 2006; Ueno et al., 2007; Chen et al., 2008; Han et al.,
2009). In all experimental groups, morphological parameters
remained significantly altered. The morphometric data based on
our published studies (Han et al., 2009; Serrano et al., 2010)
are summarized in Table 2. As with Li and HCys exposures, the
affected EtOH-exposed embryos displayed significant intrauter-
ine growth retardation (body weight, BW) and smaller placental
Table 2 | Morphological Parameters to the EtOH, Lithium, and HCys
treated E15.5.
CRL (mm) BW (gm) PW (gm)
Normal control (n = 24) 15.33 0.44 0.13
EtOH (n = 26) 12.85*** 0.39* 0.10***
Li (n = 23) 13.35*** 0.36*** 0.11**
HCys (n = 30) 13.1*** 0.36*** 0.11***
Each treatment group vs. normal control (NC) group was calculated to get a
probability (p) value (t-test): A p-value < 0.05 was considered significant; *p <
0.05; **p < 0.0005; ***p < 0.000005.
weight (PW). Peripheral Doppler changes included increased
placental resistance and possibly increased lower body systemic
resistance.
These morphometric changes in embryonic and placental size
may relate to the above-mentioned altered vascularity (Reynolds
et al., 2006). The compromised vessel development seemingly is
due to the exposure effects decreasing hematocrit and viscosity
(Lucitti et al., 2007), and reducing trophoblast invasion of the
maternal blood vessels. All three mechanisms may be involved.
Cigarette smoke effects
A similar reduced vascularization of the fetoplacental arterial tree
has been shown to occur with embryonic exposure to cigarette
smoke toxins using micro-computed tomography (Rennie et al.,
2014). In fetal sheep, the intraplacental arteries, arterioles, cap-
illaries, and venules of the arterial tree represent ∼55% of
resistance across the fetoplacental circulation with the rest pri-
marily based in the umbilical artery (Adamson et al., 1989).
Our data reflecting smaller placentas that were observed with
our environmental exposures and the possible compromise of
trophoblast invasion of the arterial bed would suggest the devel-
opment of a compromised vascular system: We demonstrated
using the human trophoblast cell line HTR-8/SVneo studies that
trophoblast migration is decreased with environmental expo-
sures, but not cell proliferation (Han et al., 2012). This would
result in poor trophoblast invasion of the spiral arteries and ulti-
mately relate to poorer exchange of nutrients, gases, and waste
products. It would be expected that these changes would facilitate
the development of intrauterine growth restricted embryos and
the CHDs that were observed and also the increase in numbers of
resorbed embryos that we reported with the three experimental
exposures.
We have reported in the mouse model multiple cellular-
molecular changes that take place in the mammalian placenta
with environmental exposures. The labyrinth appears disorga-
nized with a thinner maternal decidua apparent in the smaller
placentas in comparison to control placentas (Han et al., 2012). As
based upon some of the above described studies, it is expected that
reduced and disorganized vascularization would relate to the poor
myocardial performance, alterations of intraembryonic hemody-
namic blood flow forces, and to the CHDs, including of the valves,
that we reported (Chen et al., 2008; Han et al., 2009). In our anal-
ysis of one cardiac cycle of the embryonic avian heart, the highest
blood flow forces and cardiac jelly displacement related to the
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region that subsequently gives rise to the endocardial cushions
during valve development (Garita et al., 2011). Similar conclu-
sions in regards to impact of changes in hemodynamic forces on
valve development are reached by investigators in this volume,
as well as by others (Hogers et al., 1999; Butcher and Markwald,
2007; Vermot et al., 2009; Tan et al., 2011; Peterson et al., 2012).
CONCLUSION
In conclusion, with poor vascularization and reduced trophoblast
invasion, hemodynamics of flow to the embryonic heart is altered
and heart function is compromised. In turn in a closed system,
the decreased cardiac contractility would lead to decreased flow
forces in the umbilical artery returning blood to the placenta. It
appears there are continuous adaptive changes in both the devel-
oping heart and in the placenta to accommodate the embryo’s
needs as it grows. In response to the physiological effects of the
environmental insults, changes in flow forces are detected in the
cross-talk between the respective organs, and adaptive changes to
normalize development may no longer be met and increasingly
lead down the path toward CHDs.
As seen in this Special Topics issue and in previous stud-
ies, we now have ample evidence that biomechanics and blood
flow parameters are of critical importance in heart and vascular
morphogenesis and growth of the embryo and fetus. The hemo-
dynamic studies that have been carried out in mouse and human
pregnancy, and the environmental studies in animal models sug-
gest that an important component that needs to be taken into
consideration in themammalianmodel is the yolk sac and placen-
tal blood flow. With use of avian, zebrafish, and transgenic mouse
models in which gene expression can be conditionally modulated
to target either the heart or placenta, these future studies will
enable us to better understand the contribution of extraembry-
onic blood flow and specific blood flow parameters necessary for
normal embryonic/fetal cardiovascular development and those
that will lead to dysmorphogenesis. It will be possible to use the
quantitative measurements on flow changes in the modeling of
biophysical forces and effects on subsequent cardiac structural
development in order to define more precisely those threshold
hemodynamic force changes that lead to the different types of
anomalies that are observed.
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